Skip to Main Content Menu Search Site

DNA Nanoswitches: “Lab-on-a-Molecule” Drug Discovery

DNA nanotechnology-based platform for high-throughput, low-cost screening of small molecules and biologics to enable discovery of first-in-class therapeutics for various conditions

Want to collaborate?

We seek to create unique collaborations with academic institutions, industry, investors, foundations, and philanthropists who share our vision of bridging the divide between breakthrough scientific discovery and commercial impact.


Molecular Robotics

Technology Development Team
Wesley Wong William Shih Clinton Hansen Mark Lipstein Andrew Ward Ken Carlson Sylvie Bernier Bill Bedell
Key Features
  • High-throughput, function-based discovery of new drug candidates
  • Assays can be designed for diverse types of target proteins
  • Modular approach enables screening of a wide range of therapeutic compounds
Close menu